Dr. Jill Helms, and associate! Photo courtesy Stanford University Jill Helms is not your average Stanford University faculty member. Yes, she is a professor in the Department of Surgery. Yes, she has published lots of scientific studies. Yes, she is a stem cell scientist (funded by CIRM). And yes, she is playing a leading role … Continue reading The researcher who is following her bliss, and tackling diseases of aging at the same time
Ankasa Regenerative Therapeutics
Building a gene and cell therapy pipeline
Dr. Kelly Shepard By Dr. Kelly Shepard We love sharing exciting news about recent discoveries or announcing the launch of a new CIRM-funded clinical trial because they offer tangible signs of progress, but the background work to build a gene and cell therapy "pipeline" is no less important. Behind the scenes Important signs of progress also happen … Continue reading Building a gene and cell therapy pipeline
Stem Cell Agency Awards Almost $4 Million to Develop a Treatment for Spinal Degeneration
Today the governing Board of the California Institute for Regenerative Medicine (CIRM) awarded $3.9 million to Ankasa Regenerative Therapeutics for a promising approach to treat a degenerative condition that can cause chronic, progressive back pain. As we get older, the bones, joints and ligaments in our back become weak and less able to hold the … Continue reading Stem Cell Agency Awards Almost $4 Million to Develop a Treatment for Spinal Degeneration
Translating great stem cell ideas into effective therapies
In science, there are a lot of terms that could easily mystify people without a research background; “translational” is not one of them. Translational research simply means to take findings from basic research and advance them into something that is ready to be tested in people in a clinical trial. Yesterday our Governing Board approved … Continue reading Translating great stem cell ideas into effective therapies